RYTM
RYTM
NASDAQ · Biotechnology

Rhythm Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$107.55
+1.36 (+1.28%)
As of Jun 24, 9:50 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -6.0% upside
Low Target $80.78
Average Target $101.09
High Target $123.16
Current Price $107.55
Current
$107.55
Target
$101.09
$80.78 $101.09 avg $123.16
Scenario Analysis
Bear Case
$80.78
-24.9%
Low target
Base Case
$101.09
-6.0%
Avg target
Bull Case
$123.16
+14.5%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$122.20
-12.0% from high
52-Week Low
$60.70
+77.2% from low
50-Day SMA
$105.86
+1.6% vs SMA
200-Day SMA
$92.90
+15.8% vs SMA
RSI (14)
49.1
Neutral
Target vs 52W High
$101.09
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%